{"transactions":[{"id":2958846,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":144921,"kind":"person","name":"Lavan Keith","position":1,"cik":"0001833345","reported_name":"Lavan Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-04T02:58:34.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":975,"ownership":{"direct":false,"nature":"By Metuchen Therapeutics, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1964.29 units of Metuchen Pharmaceuticals, LLC (\"Metuchen\") in connection with the merger (the \"Merger\") of Metuchen into Petros Pharmaceuticals, Inc. (\"Petros\").  Mr. Lavan's holding of units of Metuchen was on a look-through basis based on proportionate ownership of Metuchen Therapeutics, LLC, which owned 550,000 units of Metuchen. On the effective date of the Merger, the closing price of Petros was $3.99 per share."}],"balance_after":975,"source":{"system":"sec-edgar","filing":"0001567619-20-020631","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761920020631/doc1.xml","form_type":"4"}}]}